Details for New Drug Application (NDA): 060567
✉ Email this page to a colleague
NDA 060567 describes TERRAMYCIN, which is a drug marketed by Pfizer and Casper Pharma Llc and is included in eight NDAs. Additional details are available on the TERRAMYCIN profile page.
The generic ingredient in TERRAMYCIN is oxytetracycline hydrochloride; polymyxin b sulfate. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride; polymyxin b sulfate profile page.
The generic ingredient in TERRAMYCIN is oxytetracycline hydrochloride; polymyxin b sulfate. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride; polymyxin b sulfate profile page.
Summary for 060567
| Tradename: | TERRAMYCIN |
| Applicant: | Pfizer |
| Ingredient: | lidocaine hydrochloride; oxytetracycline |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2%;50MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2%;125MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
